Ras Al Khaimah-based Gulf Pharmaceutical Industries (Julphar) has recorded a 22.5% rise in total sales of medicinal products during the first quarter of 2010, compared to the same period last year. Sales revenue during the first three months of 2010 rose to Dhs245m ($66m) from Dhs200m during the same period last year. Julphar's best selling medicine "Adol" also saw a 91.6% rise in sales to Dhs13m, compared to Dhs6.7m during the same period in 2009.